The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.
Sedliarou I, Saenko V, Lantsov D, Rogounovitch T, Namba H, Abrosimov A, Lushnikov E, Kumagai A, Nakashima M, Meirmanov S, Mine M, Hayashi T, Yamashita S.
Sedliarou I, et al. Among authors: rogounovitch t.
Int J Oncol. 2004 Dec;25(6):1729-35.
Int J Oncol. 2004.
PMID: 15547711